文献速递泌尿生殖腹部MR

前列腺HIFU半消融后无复发患者的晚期MRI表现

High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients.
PubMed 文献 · Eur J Radiol · 2021-09-17

本研究回顾性分析一项前瞻性多中心HIFU半消融试验中30例无复发患者(ISUP 1-2级)的约12个月MRI随访,评估六类HIFU相关影像特征。结果显示消融叶萎缩(93%)、残余前列腺组织(93%)、液性腔(97%,90%与尿道相通)和纤维化(97%)非常常见,而血肿残留和对比增强较少见。

要点

  • 无复发患者晚期MRI常见消融叶萎缩、残余组织、液性腔和纤维化。
  • 液性腔多与尿道相通,边缘强化或弥漫强化较少见。
  • 判读HIFU后MRI需熟悉这些常见术后改变,避免误判为复发。

关键影像表现/征象

  • 消融叶萎缩见于93%病例,平均体积变化-37%(范围-70%至+108%),对侧叶体积基本不变(平均-2%,p=0.804)。
  • 消融叶纤维化频率97%,残余前列腺组织93%,液性腔97%且90%与尿道相通。
  • 前列腺内血肿残留47%,精囊血肿残留10%。
  • 消融区对比增强呈边缘样50%、弥漫性33%。

局限性

  • 回顾性分析,样本量较小(30例)。
  • 仅纳入无复发患者,未与复发患者对比。
  • 随访时间约12个月,缺乏更长期数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Focal therapy with high-intensity focused ultrasound (HIFU) is an emerging option for the treatment of prostate cancer and often followed up by MRI. Image assessment of treatment failure, however, requires proper knowledge about typical procedure-related changes in prostate MRI, which is sparse, in particular for unilateral HIFU treatment and late follow up (beyond 6 months). The goal of this study was therefore to compile the type and frequency of such MRI findings in selected patients without recurrent cancer 12 months after prostate hemiablation.

METHODS: Data from a prospective multicenter trial on HIFU hemiablation were reviewed retrospectively. Trial patients have had a late follow-up by MRI (at around 12 months) and either MRI/transrectal ultrasound (TRUS) fusion or standard TRUS-guided biopsy. This work deliberately included patients with non-recurrent cancer in the treated prostate lobe in per-protocol biopsy leaving 30 men with initial International Society of Urological Pathology (ISUP) Grade Group of 1 or 2. Six categories of potential HIFU-related MRI features were assessed by an expert committee and then evaluated by two readers in consensus: 1. shrinkage of the treated lobe, 2. residual prostate tissue, 3. fluid-filled cavity, 4. fibrosis, 5. hematoma residuals (in the prostate or seminal vesicles) and 6. contrast enhancement of the ablated area.

RESULTS: Shrinkage of the ablated lobe was seen in 93% of the cases with an average percent volume change of -37% (range: -70% to +108%). In the contralateral lobe, the volume remained practically the same (-2% on average, p = 0.804). In the ablated lobe, the frequency of fibrosis was 97%. Residual prostate tissue was seen in 93% of the cases. The frequency for fluid-filled cavities was 97%, with the wide majority (90%) contiguous with the urethra. Hematoma residuals in the prostate and in seminal vesicles were found in 47% and 10% of the patients, respectively. Contrast enhancement was both rim-like (50%) as well as diffuse (33%) within the ablated area.

CONCLUSION: In our case series of HIFU hemiablation in the prostate, shrinkage, residual prostate tissue, fluid-filled cavities contiguous with the urethra and fibrosis were very common late MRI findings of the ablated lobe in non-recurrent patients. Rim-like contrast enhancement or diffuse one within the ablated area were less frequent.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Schaudinn A, Michaelis J, Franz T, et al. High-intensity focused ultrasound (HIFU) hemiablation of the prostate: Late follow-up MRI findings in non-recurrent patients. Eur J Radiol. 2021. PMID: 34601322. doi:10.1016/j.ejrad.2021.109957

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。